Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.

NCT03608514 is registered in ClinicalTrials.gov with National Hepatology & Tropical Medicine Research Institute as lead sponsor.

NCT NCT03608514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03608514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.
Lead sponsor
National Hepatology & Tropical Medicine Research Institute
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 1, 2018
Completion date
December 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resolution of septic shock with terlipressin